Sleep Number net sales fall 19.6% in third quarter
Reuters
Nov 05
Sleep Number net sales fall 19.6% in third quarter
Sleep Number Corporation reported third quarter 2025 results with net sales of $343.0 million, a decrease of 19.6% year-over-year, primarily due to lower volume and a reduced store count. The company recorded a net loss of $40.0 million, or $1.73 per diluted share, a decline of $37.0 million from the prior year. Adjusted EBITDA was $13.0 million, down 52.0%, with an adjusted EBITDA margin of 3.9%, a decrease of 260 basis points. Net cash used in year-to-date operating activities was $5.0 million, while free cash flow was a use of $17.0 million. The company's leverage ratio was 5.0x EBITDAR, below the amended covenant maximum of 5.25x. Sleep Number successfully amended and extended its bank agreement through 2027 and achieved fixed cost reductions in 2025. The company plans to invest in growth in 2026 and is making strategic shifts in product, brand positioning, and distribution to drive consumer demand.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sleep Number Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20251104208520) on November 05, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.